Description
A multicenter clinical trial evaluating chimeric antigen receptor-T cell therapy (CAR-T cell therapy) for stiff person syndrome (SPS), a rare autoimmune neurologic disorder, has produced promising results that are already changing lives.
The study, published in Jama Neurology, found evidence of substantial clinical improvement among participants treated with CAR-T cell therapy. Researchers say the findings warrant further investigation.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: To access clean and NAT sound versions of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/
Mayo Clinic: https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic
Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic